MAOMING YUECHUANG ADVERTISING CO., LTD. – Trademark Portfolio

Entity Type: 99

MAOMING YUECHUANG ADVERTISING CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ANTYMAN and AXEMDEYNO. The owner is based in MAOMING.

ROOM 17, FIRST FLOOR, NO. 3 AND 4, NO. 16, WENGUANG 1ST STREET, GUANGHUA ROAD

MAOMING , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AXEMDEYNO
AXEMDEYNO
Registered 2025
ANTYMAN
ANTYMAN
Registered 2020

Trademark Classifications

MAOMING YUECHUANG ADVERTISING CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MAOMING YUECHUANG ADVERTISING CO., LTD. have?

MAOMING YUECHUANG ADVERTISING CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MAOMING YUECHUANG ADVERTISING CO., LTD. file in?

MAOMING YUECHUANG ADVERTISING CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MAOMING YUECHUANG ADVERTISING CO., LTD.'s most well-known trademarks?

MAOMING YUECHUANG ADVERTISING CO., LTD.'s registered trademark portfolio includes well-known marks such as ANTYMAN and AXEMDEYNO. These are among 2 currently registered trademarks in the portfolio.

What is MAOMING YUECHUANG ADVERTISING CO., LTD.'s trademark registration success rate?

MAOMING YUECHUANG ADVERTISING CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.